Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,999.00 JPY | +0.33% |
|
-1.67% | -10.61% |
Chart calendar Towa Pharmaceutical Co., Ltd.
8534708f5c67b95.DqqXw-V81eDh4BtGVSVvvJV_CgFd0lE5r0PnSSaqZwc.dOLzjKwJgIWXsX0zHGIW3fFNXjUYoBtJxSazeQuTM013x9yZlQiHrJWTTg~cc4363370337a69fe0e78e5108bed9f0
Upcoming events on Towa Pharmaceutical Co., Ltd.
Past events on Towa Pharmaceutical Co., Ltd.
Past dividends on Towa Pharmaceutical Co., Ltd.
2025-03-27 | Final Payment 40 JPY |
2024-09-26 | Interim Payment 30 JPY |
2024-03-27 | Final Payment 30 JPY |
2023-09-27 | Interim Payment 30 JPY |
2023-03-29 | Final Payment 30 JPY |
2022-09-28 | Interim Payment 30 JPY |
2022-03-29 | Final Payment 33 JPY |
2021-09-28 | Interim Payment 24 JPY |
2021-09-28 | Bonus Payment 3 JPY |
2021-03-29 | Final Payment 22 JPY |
2020-09-28 | Interim Payment 22 JPY |
2020-03-29 | Final Payment 22 JPY |
2019-09-26 | Interim Payment 22 JPY |
2019-03-26 | Final Payment 60 JPY |
2018-09-25 | Interim Payment 47.5 JPY |
2018-03-27 | Final Payment 47.5 JPY |
2017-09-26 | Interim Payment 47.5 JPY |
2017-03-28 | Final Payment 47.5 JPY |
2016-09-27 | Interim Payment 47.5 JPY |
2016-03-28 | Final Payment 47.5 JPY |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 165 615 169 112 -2.07% | 208 859 211 570 -1.28% | 227 934 229 894 -0.85% | 259 594 261 522 -0.74% | 279 568 | 292 639 |
EBITDA Million JPY | Released Forecast Spread | 30 159 32 414 -6.96% | 24 923 25 332 -1.62% | 35 535 33 967 4.62% | 43 341 42 920 0.98% | 49 161 | 51 128 |
EBIT Million JPY | Released Forecast Spread | 19 205 21 036 -8.7% | 5 514 10 188 -45.88% | 17 647 15 794 11.73% | 23 242 23 824 -2.44% | 26 718 | 28 836 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 22 246 23 128 -3.81% | 4 605 10 390 -55.68% | 24 459 19 663 24.39% | 26 330 24 749 6.39% | 25 148 | 27 180 |
Net income Million JPY | Released Forecast Spread | 15 914 16 572 -3.97% | 2 201 5 861 -62.45% | 16 173 12 715 27.2% | 18 986 15 634 21.44% | 17 547 | 19 630 |
EPS JPY | Released Forecast Spread | 323 337 -3.94% | 44,7 119 -62.43% | 329 258 27.2% | 386 318 21.43% | 356 | 399 |
Announcement Date | 13/05/22 | 15/05/23 | 14/05/24 | 15/05/25 |
Quarterly results
Fiscal Period | September | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 68 454 72 095 -5.05% | 54 548 51 100 6.75% | 52 848 52 584 0.5% | 107 396 109 100 -1.56% | 60 929 55 735 9.32% | 59 609 61 606 -3.24% | 62 566 61 500 1.73% | 60 838 59 733 1.85% | 123 404 | 70 333 70 103 0.33% | 69 341 | 67 898 | 66 250 | 74 650 | 68 300 |
EBITDA Million JPY | Released Forecast Spread | 9 116 2 894 215% | ||||||||||||||
EBIT Million JPY | Released Forecast Spread | 162 2 548 -93.64% | 4 096 3 000 36.53% | 2 907 3 751 -22.51% | 7 003 7 500 -6.63% | 6 201 3 210 93.16% | 4 443 2 496 78.04% | 5 672 3 857 47.07% | 4 841 3 350 44.51% | 10 513 | 8 098 8 089 0.11% | 6 421 | 6 042 | 4 277 | 5 763 | 9 049 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 7 140 | 3 252 5 050 -35.6% | 10 392 | 6 898 1 902 262.67% | 7 169 2 609 174.78% | 8 584 3 570 140.45% | 1 716 1 891 -9.25% | 10 300 | 11 531 8 327 38.49% | 2 482 | 6 675 | 4 153 | 6 326 | 3 997 | |
Net income Million JPY | Released Forecast Spread | 217 1 716 -87.35% | 4 750 1 740 172.99% | 2 203 1 800 22.39% | 6 953 5 700 21.98% | 4 565 1 241 267.85% | 4 655 1 046 345.05% | 5 495 2 548 115.66% | 1 060 1 891 -43.95% | 6 555 | 8 069 4 611 74.98% | 2 869 | 3 968 | 2 953 | 3 974 | 5 300 |
EPS JPY | Released Forecast Spread | 96,5 | 44,8 24,4 83.53% | 141 | 92,8 28,4 226.12% | 94,6 -14,7 742.65% | 112 52,3 113.47% | 21,5 49,6 -56.61% | 133 | 164 57,7 184.31% | 114 | 63,5 | 62,0 | 73,6 | 161 | |
Announcement Date | 15/05/23 | 10/08/23 | 13/11/23 | 13/11/23 | 13/02/24 | 14/05/24 | 08/08/24 | 12/11/24 | 12/11/24 | 13/02/25 | - | - | - | - | - |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-16 | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
2025-07-22 | TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected) |
2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected) |
Past sector events for Towa Pharmaceutical Co., Ltd.
2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-09 04:48 am | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
2025-06-08 08:01 pm | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-06 04:47 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-05 04:37 am | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
2025-06-03 04:35 am | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
2025-05-30 09:46 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release |
2025-05-29 07:00 am | ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release |
2025-05-29 04:31 am | ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4553 Stock
- Calendar Towa Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions